Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      19 trials found for Lung cancer, Lung Neoplasm, Lung Carcinoma

      All(19)
      Recruiting(16)
      Not yet recruiting(3)
      Recruiting
      NCT03460977
      PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

      Castration Resistant Prostate Cancer (CRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)

      Male or Female
      18+ years
      126study location(s)
      Recruiting
      NCT05546476
      Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15

      Non-small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer, Loss of Appetite, Fatigue, Cachexia

      Male or Female
      18+ years
      242study location(s)
      Recruiting
      NCT05355701
      A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors.

      Melanoma, Colorectal Cancer, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma

      Male or Female
      16+ years
      70study location(s)
      Recruiting
      NCT04553133
      PF-07104091 as a Single Agent and in Combination Therapy

      Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer

      Male or Female
      18+ years
      80study location(s)
      Recruiting
      NCT05233436
      PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors

      Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer, Urothelial Cancer, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinomas

      Male or Female
      18 - 99 years
      22study location(s)
      Recruiting
      NCT04155541
      Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice)

      EGFR Mutation-positive Inoperable or Reccrent NSCLC

      Male or Female
      0+ years
      1study location(s)
      Recruiting
      NCT03375242
      Safety and Efficacy of Xalkori ROS1

      Non-small Cell Lung Cancer

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT05948462
      Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib

      Lung Cancer, Non-small Cell Lung Cancer

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT03844464
      Safety and Efficacy of Lorbrena

      Non-small Cell Lung Cancer

      Male or Female
      0+ years
      1study location(s)
      Recruiting
      NCT05160922
      Crizotinib Continuation Clinical Study

      NSCLC, ALCL, IMT

      Male or Female
      1 - 99 years
      14study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(19)
      Recruiting(16)
      Not yet recruiting(3)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.